Evidence map›Paper›PMID 32467566›Full record

ArticleThe pharmacogenomics journal2020

Association of HLA-DRB1*04:05 allele with drug-induced interstitial lung disease in Japanese population.

Takuya Imatoh, Atsuhito Ushiki, Masao Ota, Michiko Ito, Akihiro Sekine, Taiki Yamashita, Yoichi Mashimo, Ryosuke Nakamura, Kosuke Saito, Yoshiro Saito and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The pharmacogenomics journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Research Progress of Anti-lung Cancer Drug-related Interstitial Lung Disease].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Drug-induced lung disease: a narrative review.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Takuya Imatoh *Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
Atsuhito Ushiki *The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Masao Ota *Department of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
Michiko ItoThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Akihiro SekineCenter for Preventive Medical Science, Chiba University, Chiba, Japan.
Taiki YamashitaCenter for Preventive Medical Science, Chiba University, Chiba, Japan.ORCID http://orcid.org/0000-0002-5465-534X
Yoichi MashimoCenter for Preventive Medical Science, Chiba University, Chiba, Japan.
Ryosuke NakamuraDivision of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
Kosuke SaitoDivision of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
Yoshiro SaitoDivision of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan. yoshiro@nihs.go.jp.ORCID http://orcid.org/0000-0002-6669-8152
Masayuki HanaokaThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan. masayuki@shinshu-u.ac.jp.ORCID http://orcid.org/0000-0002-8584-8515
Shinshu University · JPChiba University · JPNational Institute of Health Sciences · JPNational Institute of Occupational Safety and Health · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced interstitial lung disease (DILD) is a life-threatening adverse reaction. The Japanese population is more susceptible to DILD as compared with other populations, suggesting its pathogenesis could vary depending on ethnic genetic background. We conducted case-control studies to elucidate the association between DILD and HLA alleles in the Japanese. The 177 clinically diagnosed DILD patients and 3002 healthy controls for exploration and 55 DILD patients and 201 healthy controls for validation were genotyped for four HLA genes. HLA-DRB1*04:05 was significantly associated with DILD (corrected p = 0.014); this was also validated in the other set of patients/controls. Chemical drugs other than protein therapeutics showed this association (p = 1.7 × 10

Indexed as

AllelesAdultCase-Control StudiesDrug-Related Side Effects and Adverse ReactionsFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHLA-DRB1 ChainsHumansJapanLung Diseases, InterstitialMaleMiddle AgedPopulation SurveillanceHLA-DRB1*04:05 antigenHLA-DRB1 Chains

Identifiers

PMID32467566
OpenAlexW3031459560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.